Keto Diet's Cancer-Fighting Potential: Does It Work?

The ketogenic diet, or keto, is a very high-fat, low-carbohydrate way of eating. It is believed by some to be an effective treatment for cancer, but there is currently no consensus on its efficacy. The keto diet causes the body to enter a state of ketosis, where fat is burned for energy instead of carbohydrates. This is thought to starve cancer cells of fuel, as they rely on glucose for energy. While some studies have shown that keto may slow the growth of some types of tumours, others have found that it could worsen cancer by promoting tumour growth. The diet is also associated with heart disease and obesity, and it can be challenging to adhere to long-term. More research is needed to determine the effectiveness of the keto diet as a cancer treatment.

The ketogenic diet may slow cancer by inhibiting insulin/IGF and downstream intracellular signalling pathways, such as phosphoinositide 3-kinase (PI3K)

The ketogenic diet (KD) is a low-carbohydrate, high-fat, and moderate-protein diet that induces a metabolic state called ketosis. This diet has been explored as a potential complementary strategy in cancer treatment due to its ability to target the metabolic processes of cancer cells.

The potential anticancer properties of the ketogenic diet are attributed to its ability to slow cancer by inhibiting insulin/IGF and downstream intracellular signalling pathways, such as phosphoinositide 3-kinase (PI3K). Here's a more detailed explanation:

Insulin and Insulin-Like Growth Factor (IGF):

Glucose is a simple sugar that our body uses for energy. When we consume carbohydrates, our body breaks them down into glucose. In response to increased glucose and carbohydrate intake, the pancreas releases insulin. Insulin is a hormone that allows glucose to enter cells and provide them with energy. In healthy individuals, insulin stimulates glucose uptake and utilisation, maintaining normal blood glucose levels. However, in cancer patients, high insulin levels can promote cell growth and proliferation, which is detrimental. This is where the ketogenic diet comes into play.

By significantly reducing carbohydrate intake, the ketogenic diet lowers blood glucose and insulin levels. This reduction in insulin inhibits the production of insulin-like growth factor 1 (IGF-1) in the liver. IGF-1 is a hormone similar to insulin that can promote the growth and proliferation of cancer cells. By suppressing insulin and IGF-1, the ketogenic diet creates an unfavourable metabolic environment for cancer cells, potentially hindering their growth.

Downstream Intracellular Signalling Pathways:

The inhibitory effects of the ketogenic diet on insulin and IGF-1 also impact downstream intracellular signalling pathways, including the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway. This pathway is crucial for cell growth, proliferation, and survival. By inhibiting this pathway, the ketogenic diet further disrupts the cancer cells' ability to grow and proliferate.

Additional Mechanisms:

In addition to inhibiting insulin/IGF and downstream pathways, the ketogenic diet also amplifies adenosine monophosphate-activated protein kinase (AMPK). AMPK inhibits aerobic glycolysis and suppresses tumour proliferation, invasion, and migration. The ketogenic diet also increases the production of beta-hydroxybutyrate, which can modify chromatin and inhibit histone deacetylase, ultimately curbing cancer cell proliferation.

While more research is needed, the ketogenic diet shows potential as a complementary approach in cancer treatment by targeting these metabolic pathways and creating an unfavourable environment for cancer cells.

The diet may be more effective when combined with standard cancer treatments, such as chemotherapy and radiotherapy

The ketogenic diet, or keto diet, is a very low-carb, high-fat diet that shares similarities with other low-carb diets, such as the Atkins diet. It involves significantly reducing carbohydrate intake and replacing it with fat and protein. This change leads to a metabolic state called ketosis, in which fat becomes the body's primary energy source.

The keto diet has been studied as a potential tool in cancer treatment, with some research suggesting it may be effective in reducing tumour growth and improving survival rates. However, most of the studies have been conducted on animals, and there is limited research on its effects on humans.

While the keto diet may show potential in cancer treatment, it should not be used as a standalone treatment. Combining the keto diet with standard cancer treatments, such as chemotherapy and radiotherapy, may be a more effective approach. This is supported by the following:

• A 2010 case study published in Nutrition & Metabolism examined the effects of treating a glioblastoma, an aggressive form of brain tumour, with a combination of standard therapy and a restricted ketogenic diet. The 65-year-old female patient followed a very low-calorie ketogenic diet after surgery, and during this time, the tumour's progression slowed. However, when she returned to a normal diet, she experienced a significant increase in tumour growth.
• A study by Zuccoli et al. examined the effects of a ketogenic diet in combination with oral chemotherapy on a patient with glioblastoma multiforme. The patient showed good tumour control for about a year before discontinuing the diet and transitioning to chemotherapy.
• A study by Nebeling et al. in 1995 examined the effects of a ketogenic diet on two girls undergoing treatment for advanced brain cancer. Researchers found that glucose uptake was decreased in the tumours of both girls. One of the girls reported an improved quality of life and remained on the diet for 12 months, during which her disease showed no further progression.
• A study by Champ et al. in 2014 investigated the effects of a ketogenic diet in combination with standard cancer treatments on five patients with glioma. Three out of five patients experienced complete remission after adopting the ketogenic diet along with radiation or chemotherapy. The other two participants experienced a progression of the disease after discontinuing the ketogenic diet.

These studies provide preliminary evidence that the keto diet may be more effective when combined with standard cancer treatments. However, more research is needed to confirm these findings and understand the underlying mechanisms. It is important to note that cancer patients should always consult their oncologist before making any dietary changes or adopting alternative treatments.

The diet may not be suitable for everyone and could even cause harm, particularly in those with pre-existing health conditions

The ketogenic diet is not suitable for everyone and could even cause harm, particularly to those with pre-existing health conditions.

The diet is very high in fat, with fat intake making up to 70% of total calorie intake, or even higher. Many foods allowed on the diet, such as red meat, have been shown to increase the risk of some cancers. The diet is also very restrictive, limiting foods known to prevent cancer, such as whole grains, fruits, and some vegetables.

Compliance with the diet is poor, making it challenging for people with cancer. The restrictive nature of the diet can be too much for some people, especially when food can be a source of comfort.

The diet is not appropriate for everyone and could even cause harm. For instance, it may be harmful to those with pre-existing health conditions, such as diabetes or cardiovascular disease. It is important to speak with a medical professional before starting the ketogenic diet to determine if it is right for you.

Some studies have found that a ketogenic diet may be harmful in certain contexts. For example, one study found that the keto diet made one type of blood cancer worse in mice. Another study found that a ketogenic diet accelerated certain leukemias.

Additionally, the keto diet may be challenging for those undergoing traditional cancer therapies to consume enough calories. Low-carb diets, such as ketogenic diets, often result in weight loss, which may not be desirable for cancer patients already struggling with weight loss.

Furthermore, the keto diet can be difficult to stick to, and compliance is poor. This makes it challenging for people with cancer who are already dealing with a lot of other challenges.

In conclusion, while the ketogenic diet may have potential benefits for cancer treatment and prevention, it is not suitable for everyone and could even cause harm. It is important to speak with a medical professional before starting any new diet, especially if you have pre-existing health conditions.

The diet may be beneficial for weight loss, which is helpful for reducing cancer risk, especially in obese and older people

The keto diet is a very low-carb, high-fat diet that shares similarities with other low-carb diets, such as the Atkins diet. It involves reducing carbohydrate intake and replacing it with fat and protein. This diet typically provides 70% of calories from fat, 20% from protein, and 10% from carbs.

The keto diet is a powerful weight-loss tool, and weight loss is beneficial for reducing cancer risk, especially in obese and older individuals, including those in the postmenopausal age group. Research suggests that the keto diet may be effective for weight loss in the short term, although its long-term safety and ability to maintain weight loss are unclear.

The keto diet can be challenging to adhere to, and it is very restrictive in terms of foods known to prevent cancer, such as whole grains, fruits, and some vegetables. Compliance with the keto diet tends to be poor, and it may be difficult for cancer patients to consume enough calories while following this diet.

While the keto diet may be beneficial for weight loss, which can reduce cancer risk, it is important to note that no major cancer group recommends it for cancer prevention or treatment. The current evidence supports a plant-based diet over a keto diet for reducing cancer risk.

The diet may be more effective for specific types of cancer, such as breast cancer with mutations in the PIK3CA gene

The ketogenic diet (KD) has been studied for its potential therapeutic effects on specific types of cancer, including breast cancer with mutations in the PIK3CA gene. While more research is needed, some studies suggest that KD may be beneficial in inhibiting tumor growth and improving treatment response in certain cancers.

The KD is a high-fat, low-carbohydrate, and moderate-protein diet that induces a state of ketosis, where the body uses ketone bodies as an alternative energy source instead of glucose. This metabolic shift can create an unfavorable environment for cancer cells, which often rely heavily on glycolysis for energy production, even in the presence of oxygen, a phenomenon known as the Warburg effect.

In breast cancer, the PI3K/Akt signaling pathway is commonly activated due to mutations in the PIK3CA gene. This pathway is crucial for cancer cell growth and proliferation. By reducing glucose and insulin levels, the KD can inhibit this pathway and disrupt cancer cell metabolism.

Some preclinical studies have shown that the KD can slow tumor growth, improve treatment response, and prolong survival in mouse models of breast cancer. However, the results of clinical trials in human patients with breast cancer have been mixed, with some studies showing potential benefits and others showing no significant difference compared to standard care.

The potential benefits of the KD in breast cancer may depend on the specific molecular subtypes and genetic mutations present. Further well-designed clinical trials are needed to conclusively determine the efficacy of the KD as an adjuvant therapy for specific types of breast cancer, such as those with mutations in the PIK3CA gene.

Frequently asked questions